Prime medicine to present at cowen 43rd annual health care conference

Cambridge, mass., feb. 27, 2023 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d., president and chief executive officer of prime medicine, will present a corporate overview at the cowen 43rd annual health care conference on monday, march 6, 2023 at 9:50 a.m. et in boston, ma.
PRME Ratings Summary
PRME Quant Ranking